Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
147,940,971
-
Share change
-
+729,773
-
Total reported value
-
$3,081,594,094
-
Put/Call ratio
-
149%
-
Price per share
-
$20.83
-
Number of holders
-
202
-
Value change
-
+$9,562,009
-
Number of buys
-
116
-
Number of sells
-
77
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q3 2018
As of 30 Sep 2018,
IMMUNOMEDICS INC - COM (IMMU) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
147,940,971 shares.
The largest 10 holders included
venBio Select Advisor LLC, Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., STATE STREET CORP, FMR LLC, Palo Alto Investors LP, ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, and JANUS HENDERSON GROUP PLC.
This page lists
202
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.